ERWIN ROBERT L 4

Accession 0001638599-19-000511

CIK 0001420720other

View on SEC.gov Company Profile

Filed

May 12, 8:00 PM ET

Accepted

May 13, 11:33 AM ET

Size

39.1 KB

Accession

0001638599-19-000511

Insider Transaction Report

Form 4

Period: 2019-02-20

iBio, Inc.IBIO

ERWIN ROBERT L

President

Transactions

Award
Stock Option (right to buy)
2019-02-20+18,750→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (18,750 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−30,000→ 232,500 total
Exercise: $17.30Exp: 2019-08-16→ Common Stock (30,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−30,000→ 232,500 total
Exercise: $19.60Exp: 2021-10-21→ Common Stock (30,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−30,000→ 232,500 total
Exercise: $11.00Exp: 2022-07-24→ Common Stock (30,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+22,500→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (22,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−30,000→ 232,500 total
Exercise: $5.00Exp: 2023-07-16→ Common Stock (30,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+22,500→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (22,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−60,000→ 232,500 total
Exercise: $10.00Exp: 2024-09-05→ Common Stock (60,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+45,000→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (45,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−25,000→ 232,500 total
Exercise: $6.60Exp: 2019-08-10→ Common Stock (25,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+22,500→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (22,500 underlying)
Award
Stock Option (right to buy)
2019-02-20+22,500→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (22,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−30,000→ 232,500 total
Exercise: $4.00Exp: 2027-05-01→ Common Stock (30,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+22,500→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (22,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−75,000→ 232,500 total
Exercise: $17.20Exp: 2025-09-04→ Common Stock (75,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+56,250→ 232,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (56,250 underlying)

Footnotes (7)

[F1]Vested in five annual instalments on anniversaries of date of grant.
[F2]On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.
[F3]Fully vests on first anniversary of grant date.
[F4]On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.
[F5]Vested 20% on 7/1/2010 and then in 20% instalments on each anniversary thereof.
[F6]Reflects number of securities beneficially owned following all transactions reported on this Form 4.
[F7]Vested in three equal annual instalments on the anniversary of the date of grant.

Documents

1 file

4
doc4_6051.xmlPrimary
PRIMARY DOCUMENT

Issuer

iBio, Inc.

CIK 0001420720

→

Entity typeother

Related Parties

filerCIK 0001213822

Filing Metadata

Form type: 4
Filed: May 12, 8:00 PM ET
Accepted: May 13, 11:33 AM ET
Size: 39.1 KB

View on SEC.gov